Amgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot, MariTide, causes excessive bone mineral density loss. Please watch the video at Investors.com - How ...
Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a day after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback